Hi Mr Dollars I understand your concerns with Point 1 - but I...

Hi Mr Dollars

I understand your concerns with Point 1 - but I don't think the world's 4th largest company with 2016 revenues of $295 billion is going to enter into a terms sheet agreement with a $20 million market cap company, just to trick them and steal their technology.

Regarding Point 2 - I don't see how this is a bad thing. It kind of neutralises your previous point - wouldn't you want the world's toughest negotiators engaging in a royalty deal with Sinopec? You've got direct exposure to some of the brightest minds on the planet at the Weizmann Institute in Israel. VIV is the only Australian company in something like the last 35 years to establish a deal with Weizmann.

Regarding Point 3 - I don't see how this is an issue. I see this as ongoing validation of the economics of the product by established brands.